BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32978753)

  • 1. Factors predicting survival in patients with locally advanced pancreatic cancer undergoing pancreatectomy with arterial resection.
    Napoli N; Kauffmann E; Cacace C; Menonna F; Caramella D; Cappelli C; Campani D; Cacciato Insilla A; Vasile E; Vivaldi C; Fornaro L; Amorese G; Vistoli F; Boggi U
    Updates Surg; 2021 Feb; 73(1):233-249. PubMed ID: 32978753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection: a retrospective cohort study.
    Miura T; Hirano S; Nakamura T; Tanaka E; Shichinohe T; Tsuchikawa T; Kato K; Matsumoto J; Kondo S
    Surgery; 2014 Mar; 155(3):457-67. PubMed ID: 24462074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular resection for locally advanced pancreatic ductal adenocarcinoma: analysis of long-term outcomes from a single-centre series.
    Feo CF; Deiana G; Ninniri C; Cherchi G; Crivelli P; Fancellu A; Ginesu GC; Porcu A
    World J Surg Oncol; 2021 Apr; 19(1):126. PubMed ID: 33866970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined hepatic arterial resection in pancreatic resections for locally advanced pancreatic cancer.
    Miyazaki M; Yoshitomi H; Takano S; Shimizu H; Kato A; Yoshidome H; Furukawa K; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Ohtuka M
    Langenbecks Arch Surg; 2017 May; 402(3):447-456. PubMed ID: 28361216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic distal pancreatectomy for pancreatic cancer is safe and effective.
    Bauman MD; Becerra DG; Kilbane EM; Zyromski NJ; Schmidt CM; Pitt HA; Nakeeb A; House MG; Ceppa EP
    Surg Endosc; 2018 Jan; 32(1):53-61. PubMed ID: 28643065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial resection during pancreatectomy for pancreatic ductal adenocarcinoma with arterial invasion: A single-center experience with 109 patients.
    Kwon J; Shin SH; Yoo D; Hong S; Lee JW; Youn WY; Hwang K; Lee SJ; Park G; Park Y; Lee W; Song KB; Lee JH; Hwang DW; Kim SC
    Medicine (Baltimore); 2020 Sep; 99(37):e22115. PubMed ID: 32925757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer?
    Amano H; Miura F; Toyota N; Wada K; Katoh K; Hayano K; Kadowaki S; Shibuya M; Maeno S; Eguchi T; Takada T; Asano T
    J Hepatobiliary Pancreat Surg; 2009; 16(6):850-7. PubMed ID: 19844653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Resections for Pancreatic Ductal Adenocarcinoma: Vascular Resections for PDAC.
    Oba A; Bao QR; Barnett CC; Al-Musawi MH; Croce C; Schulick RD; Del Chiaro M
    Scand J Surg; 2020 Mar; 109(1):18-28. PubMed ID: 31960765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.
    Michelakos T; Pergolini I; Castillo CF; Honselmann KC; Cai L; Deshpande V; Wo JY; Ryan DP; Allen JN; Blaszkowsky LS; Clark JW; Murphy JE; Nipp RD; Parikh A; Qadan M; Warshaw AL; Hong TS; Lillemoe KD; Ferrone CR
    Ann Surg; 2019 Apr; 269(4):733-740. PubMed ID: 29227344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement.
    Perinel J; Nappo G; El Bechwaty M; Walter T; Hervieu V; Valette PJ; Feugier P; Adham M
    Langenbecks Arch Surg; 2016 Dec; 401(8):1131-1142. PubMed ID: 27476146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign?
    Belfiori G; Fiorentini G; Tamburrino D; Partelli S; Pagnanelli M; Gasparini G; Castoldi R; Balzano G; Rubini C; Zamboni G; Crippa S; Falconi M
    Surgery; 2021 Feb; 169(2):403-410. PubMed ID: 32912782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
    Hartwig W; Gluth A; Hinz U; Koliogiannis D; Strobel O; Hackert T; Werner J; Büchler MW
    Br J Surg; 2016 Nov; 103(12):1683-1694. PubMed ID: 27686238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Indications of Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Body/Tail Cancer.
    Sugiura T; Okamura Y; Ito T; Yamamoto Y; Uesaka K
    World J Surg; 2017 Jan; 41(1):258-266. PubMed ID: 27473130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robotic and open distal pancreatectomy with celiac axis resection for locally advanced pancreatic body tumors: a single institutional assessment of perioperative outcomes and survival.
    Ocuin LM; Miller-Ocuin JL; Novak SM; Bartlett DL; Marsh JW; Tsung A; Lee KK; Hogg ME; Zeh HJ; Zureikat AH
    HPB (Oxford); 2016 Oct; 18(10):835-842. PubMed ID: 27506992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.
    Xu HX; Liu L; Xiang JF; Wang WQ; Qi ZH; Wu CT; Liu C; Long J; Xu J; Ni QX; Yu XJ
    Surgery; 2017 Feb; 161(2):373-384. PubMed ID: 27838102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Study Group of Pancreatic Surgery type 3 and 4 venous resections in patients with pancreatic adenocarcinoma:the Paoli-Calmettes Institute experience.
    Al Faraï A; Garnier J; Ewald J; Marchese U; Gilabert M; Moureau-Zabotto L; Poizat F; Giovannini M; Delpero JR; Turrini O
    Eur J Surg Oncol; 2019 Oct; 45(10):1912-1918. PubMed ID: 31186204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.
    Chen K; Pan Y; Huang CJ; Chen QL; Zhang RC; Zhang MZ; Wang GY; Wang XF; Mou YP; Yan JF
    BMC Cancer; 2021 Apr; 21(1):382. PubMed ID: 33836678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer.
    Del Chiaro M; Rangelova E; Halimi A; Ateeb Z; Scandavini C; Valente R; Segersvärd R; Arnelo U; Verbeke CS
    HPB (Oxford); 2019 Feb; 21(2):219-225. PubMed ID: 30093144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.